Israel to hold human trials on COVID-19 vaccine with 100 volunteers
The report came following an announcement in June by the IIBR on the success of the vaccine in trials on hamsters.
Follow us on GoogleA handout photo shows an employee demonstrating a vial with "Gam-COVID-Vac" vaccine against the coronavirus disease (COVID-19), developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), during its production at Binnopharm ph(photo credit: REUTERS)ByCODY LEVINE
